Beau's Lines: Drugs That Cause or Treat Them

What Beau's Lines Are and Why They Form

Beau's lines are transverse, non-pigmented depressions that run horizontally across the nail plate. They result from a temporary arrest or slowing of the nail matrix, the tissue beneath the proximal nail fold responsible for generating new nail 1. The depth of the groove correlates with the severity and duration of the matrix insult. A shallow line suggests a brief disruption; a deep groove spanning the full width of the nail indicates near-complete cessation of growth.

French physician Joseph Honoré Simon Beau first characterized these lines in 1846, associating them with systemic illness. The mechanism is now well understood. Nail matrix keratinocytes are among the most mitotically active cells in the body, dividing roughly every 18 to 24 hours 2. Any process that suppresses cell division, whether a high fever, severe infection, nutritional deficiency, or cytotoxic medication, can produce a visible groove. Because fingernails grow at approximately 3 mm per month, the distance from the groove to the proximal nail fold allows clinicians to estimate when the insult occurred 3.

This retrospective dating is clinically useful. A groove sitting 6 mm from the cuticle points to an event roughly two months prior. When multiple nails display grooves at the same distance, the cause is almost certainly systemic rather than local trauma.

Chemotherapy Agents: The Most Common Drug Cause

Cytotoxic chemotherapy represents the best-documented pharmacologic trigger for Beau's lines. These drugs target rapidly dividing cells. Nail matrix cells, given their high mitotic rate, are collateral targets.

Taxane-based regimens (docetaxel, paclitaxel) produce nail toxicity in 25% to 50% of treated patients, according to a 2017 systematic review of 2,394 patients receiving taxane chemotherapy 4. Beau's lines are among the most frequent nail findings, alongside onycholysis (nail plate separation) and pigmentary changes. Cyclophosphamide, doxorubicin, and 5-fluorouracil are also well-established causes 5.

Dr. Shari Lipner, Associate Professor of Dermatology at Weill Cornell Medicine, has noted: "Nail changes from chemotherapy are extremely common and underreported. Patients may not mention them because they seem cosmetic, but they can significantly affect quality of life and even serve as markers of treatment intensity" 6.

The pattern with chemotherapy is often distinctive. Because treatment is administered in cycles, patients may develop multiple parallel Beau's lines, each corresponding to a treatment cycle. This "washboard" pattern is nearly pathognomonic for cyclical cytotoxic exposure. In severe cases, the matrix arrest is complete enough to cause onychomadesis (full nail shedding), which represents the extreme end of the same spectrum 7.

Retinoids and Beau's Lines

Systemic retinoids, particularly isotretinoin (Accutane) and acitretin (Soriatane), are recognized causes of nail changes including Beau's lines. These vitamin A derivatives alter keratinocyte differentiation and proliferation throughout the body, and the nail matrix is no exception.

A retrospective analysis of 150 patients treated with isotretinoin for acne found nail abnormalities in 18 (12%), with Beau's lines and brittle nails being the most common presentations 8. Acitretin, used for psoriasis, carries a higher rate of nail side effects. In one cohort study of 128 psoriasis patients on acitretin, nail dystrophy (including transverse grooving) occurred in approximately 25% of subjects at standard doses of 25 to 50 mg daily 9.

The mechanism differs slightly from chemotherapy. Retinoids do not directly kill matrix cells but alter their keratinization program. The result is abnormal nail plate formation rather than complete growth arrest. This distinction explains why retinoid-induced Beau's lines tend to be shallower than those caused by cytotoxic agents.

Dose reduction often improves nail symptoms without requiring complete discontinuation. Most retinoid-associated nail changes resolve within 3 to 6 months of dose adjustment or cessation 10.

Anticonvulsants, Antiretrovirals, and Other Triggers

Several other drug classes have documented associations with Beau's lines, though the evidence base is smaller and consists largely of case reports and case series.

Anticonvulsants. Carbamazepine, phenytoin, and valproic acid have all been implicated. A case series from the Archives of Dermatology described Beau's lines in 3 of 47 epilepsy patients on long-term carbamazepine therapy 11. The proposed mechanism involves drug-induced interference with folate metabolism, which secondarily affects nail matrix cell division.

Antiretrovirals. Zidovudine (AZT) and other nucleoside reverse transcriptase inhibitors can produce nail pigmentation and Beau's lines. A study of 68 HIV-positive patients on antiretroviral therapy found nail changes in 44% of the cohort, with Beau's lines present in 8 patients (11.8%) 12.

Immunosuppressants. Azathioprine and mycophenolate mofetil, used in organ transplantation and autoimmune disease, have been associated with Beau's lines in case reports 13.

Fluoroquinolone antibiotics. Isolated case reports link ciprofloxacin to transverse nail grooves, possibly through direct matrix toxicity 14.

Beta-blockers. Rarely, propranolol and other beta-blockers have been implicated, potentially through reduced peripheral blood flow to the nail matrix.

The following framework organizes drug triggers by mechanism:

| Mechanism | Drug Class | Examples | Typical Severity | |---|---|---|---| | Direct cytotoxicity | Chemotherapy | Docetaxel, cyclophosphamide, 5-FU | Moderate to severe | | Altered keratinization | Retinoids | Isotretinoin, acitretin | Mild to moderate | | Folate interference | Anticonvulsants | Carbamazepine, phenytoin | Mild | | Mitochondrial toxicity | Antiretrovirals | Zidovudine, lamivudine | Mild to moderate | | Immune suppression | Immunosuppressants | Azathioprine, mycophenolate | Mild | | Direct matrix toxicity | Antibiotics | Ciprofloxacin | Rare, mild |

Non-Drug Causes to Rule Out First

Before attributing Beau's lines to a medication, clinicians must consider and exclude other causes. Drug-induced Beau's lines are a diagnosis of exclusion supported by temporal correlation.

Systemic illness is the most common non-drug cause. High fevers (>103°F / 39.4°C) from pneumonia, COVID-19, or other infections frequently produce Beau's lines. A 2021 observational study of 130 post-COVID patients found nail changes in 14.6%, with Beau's lines as the predominant finding appearing 3 to 4 months after acute infection 15. Peripheral vascular disease, Raynaud's phenomenon, uncontrolled diabetes, and zinc deficiency are other established causes 16.

The American Academy of Dermatology's guidelines on nail disorders recommend a systematic approach: "When evaluating transverse nail grooves, the clinician should establish the temporal relationship between the onset of the groove and any systemic illness, surgical procedure, or medication change. The number of nails involved helps distinguish systemic from local causes" 17.

Local trauma to a single nail produces an isolated Beau's line and is the most benign scenario. This can result from manicure injury, a crush injury, or habitual picking at the proximal nail fold (a habit-tic deformity that produces a characteristic midline washboard pattern on the thumbnail).

Diagnosis: Clinical Assessment and Timing

Diagnosing Beau's lines requires no special equipment. They are visible to the naked eye.

The clinical evaluation follows a straightforward sequence. First, count the affected nails. All twenty nails involved points to a severe systemic event. Several fingernails at the same groove distance suggests a single systemic insult. One nail with a groove is most likely local trauma.

Second, measure the groove's distance from the proximal nail fold. Dividing this distance by the average growth rate (3 mm/month for fingernails, 1 mm/month for toenails) yields an estimated date of the causative event. This calculation is surprisingly accurate. A 2019 study validating this method in 45 patients found that the estimated timing matched the known date of a systemic insult (surgery, chemotherapy cycle, febrile illness) within plus or minus 2 weeks in 84% of cases 18.

Third, assess groove depth. Shallow lines (less than 0.5 mm) suggest a brief or mild disruption. Deep grooves may indicate prolonged or severe matrix suppression. If the groove spans the full thickness of the nail plate, the nail may eventually shed completely (onychomadesis).

Laboratory testing is rarely needed for isolated Beau's lines with a clear temporal trigger. When the cause is unclear, checking serum zinc, iron studies, thyroid function, and a complete blood count can identify nutritional or metabolic contributors 19.

Treatment and Management: No Drug Fixes the Lines

There is no medication that accelerates nail regrowth or directly treats Beau's lines. The groove is a permanent record of a past matrix insult, embedded in the nail plate like a tree ring. It can only disappear by growing out.

Management centers on three priorities. Identify and address the trigger. If a medication is responsible, discuss with the prescribing physician whether dose reduction or substitution is feasible. For chemotherapy patients, nail changes alone rarely justify altering a cancer treatment regimen, but supportive measures can reduce severity.

Protect the nail during regrowth. Brittle, grooved nails are prone to snagging and breaking. Keeping nails trimmed short, avoiding harsh nail products, and wearing gloves during manual work reduces mechanical stress. Nail hardeners containing formaldehyde should be avoided as they can paradoxically increase brittleness 20.

Monitor for progression. If new Beau's lines continue to appear despite removal of the suspected trigger, the initial attribution may be wrong. Recurrent lines warrant re-evaluation for occult systemic disease, nutritional deficiency, or vascular insufficiency.

Biotin supplementation (2.5 mg daily) has some evidence for improving nail strength in patients with brittle nails, based on a small trial of 35 patients showing a 25% increase in nail thickness after 6 months 21. Whether this translates to faster resolution of Beau's lines specifically has not been studied. No other supplement has demonstrated benefit in controlled trials.

For chemotherapy patients, cooling gloves (frozen gel mitts worn during infusion) have shown promise in reducing nail toxicity. A randomized controlled trial of 53 breast cancer patients receiving docetaxel found that continuous cooling of one hand during infusion reduced nail toxicity from 51% to 11% on the cooled side (P<0.001) 22.

Timeline for Resolution

Fingernail Beau's lines typically grow out completely within 4 to 6 months after the causative insult ends. Toenails, growing at roughly one-third the rate, may take 12 to 18 months.

Certain factors slow this timeline. Age is one: nail growth velocity decreases by approximately 0.5% per year after age 25, meaning an 80-year-old's nails grow roughly 30% more slowly than a 25-year-old's 23. Peripheral vascular disease, diabetes, and hypothyroidism also reduce growth rates. Patients on continued immunosuppressive therapy may experience delayed regrowth even after the original trigger resolves.

There is no evidence that topical treatments, nail oils, or massage accelerate the growth rate beyond its physiologic baseline. The only validated strategy for faster cosmetic improvement is keeping nails trimmed so the grooved segment is removed mechanically as it reaches the free edge.

When to Seek Medical Evaluation

A single Beau's line on one nail after a known injury needs no workup. Multiple nails with lines at the same level, recurrent episodes, or lines accompanied by other nail changes (color change, thickening, separation from the nail bed) should be evaluated by a dermatologist.

Beau's lines on all 20 nails following a severe systemic illness are expected and self-limited. They confirm that the illness was significant enough to temporarily halt matrix function across all digits, but they do not indicate ongoing disease.

The threshold for concern is persistence or recurrence. New lines appearing every few months without an obvious cause may signal chronic intermittent vascular compromise, recurrent nutritional deficiency, or an undiagnosed autoimmune condition affecting the nail apparatus. A nail biopsy is occasionally needed to exclude lichen planus, psoriasis, or other inflammatory nail diseases that can mimic Beau's lines 24.

Patients on long-term medications associated with nail toxicity should have their nails examined at routine follow-up visits. Documenting baseline nail status before starting a new medication known to affect nails (particularly chemotherapy or retinoids) allows for more accurate attribution if changes develop later.